About Areteia Therapeutics
Areteia Therapeutics is a private company based in Chapel Hill, North Carolina, incorporated in 2022 in Delaware. It has reported $360,000,020 raised in one offering on Form D since July 2022. Its chief executive is Jorge Bartolome.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 15, 2022 | Jul 14, 2022amended Feb 21, 2025 | $360,000,020of $445.0M target | 16 | $22.5M | EquityRule 506(b) | Form D/A ↗2 earlier filings |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Areteia Therapeutics's Form D filed Feb 21, 2025.
BG
Benjamin Gomez
Director
AK
Adam Koppel
Director
IR
Ian Read
Director
MB
DB
Daniel Becker
Director
RW
Robin Walker
Executive officer
PB
Paul Berns
Director
CC
Christopher Courts
Executive officer
SB
Stephen Butts
Director
JB
Jorge Bartolome
Chief Executive Officer and director
ES
Elyse Stock
Director